Seqens Seqens

X
[{"orgOrder":0,"company":"JSC Olainfarm","sponsor":"Not Applicable","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"JSC Olainfarm & Adalvo to Launch a New Urology Product in 17 Countries In 2022-2023","therapeuticArea":"Infections and Infectious Diseases","highestDevelopmentStatus":"Approved","country":"LATVIA","productType":"Small molecule","productStatus":"Approved","date":"June 2021","url1":"","url2":"","graph1":"Infections and Infectious Diseases","graph2":"Approved"},{"orgOrder":0,"company":"Silvanols","sponsor":"Not Applicable","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"Silvanols Puts Special Emphasis on A Research-Based and Developed Agent to Strengthen the Body\u2019s Defence Abilities During This Viral Season \u2013 Go Immune Strong","therapeuticArea":"Infections and Infectious Diseases","highestDevelopmentStatus":"Approved","country":"LATVIA","productType":"Small molecule","productStatus":"Approved","date":"February 2020","url1":"","url2":"","graph1":"Infections and Infectious Diseases","graph2":"Approved"},{"orgOrder":0,"company":"Silvanols","sponsor":"University of Lorraine","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"Silvanols Launches the First Combined Product in Latvia with The Innovative Ingredient Lactium\u00ae \u2013 Against Everyday Stress","therapeuticArea":"Neurology","highestDevelopmentStatus":"Approved","country":"LATVIA","productType":"Small molecule","productStatus":"Approved","date":"March 2020","url1":"","url2":"","graph1":"Neurology","graph2":"Approved"},{"orgOrder":0,"company":"Silvanols","sponsor":"University of Latvia","pharmaFlowCategory":"DU","amount":"Not Applicable","upfrontCash":"Not Applicable","newsHeadline":"Latvia Can! A New Remedy for Respiratory Diseases Created and Researched!","therapeuticArea":"Infections and Infectious Diseases","highestDevelopmentStatus":"Approved","country":"LATVIA","productType":"Small molecule","productStatus":"Approved","date":"February 2021","url1":"","url2":"","graph1":"Infections and Infectious Diseases","graph2":"Approved"}]

Find Clinical Drug Pipeline Developments & Deals by JSC Olainfarm

Menu
Loading...
Filters Filter
×
FILTER:
filter Company
    filter Sponsor
      filter Country
        filter Therapeutic Area
          filter Study Phase

            Active Filter(s):

            Companies By Therapeutic Area

            Development Status

            Details:

            In partnership Olainfarm will manage Furagins (Furaginum) regulatory affairs, distribution and promotion in Latvia, Russia, Kazakhstan, Belarus, Ukraine, and other countries and Adalvo will be responsible for development, manufacturing and will support market activities.

            Lead Product(s): Furazidin

            Therapeutic Area: Infections and Infectious Diseases Product Name: Furagins

            Highest Development Status: Approved Product Type: Small molecule

            Partner/Sponsor/Collaborator: Not Applicable

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Agreement June 16, 2021

            JSC OlainFarm Company Banner

            Cophex 2024

            Not Confirmed

            envelop Contact Supplier

            Details:

            Goimmune Strong contains bark extract of pink tabebuia, olive leaf extract, brazilian green propolis, zinc bisglycinate and organic selenium. It promotes the protection of cells against oxidative stress and showed antibacterial activity in respiratory diseases.

            Lead Product(s): Tabebuia Avellandae,Olea Europea,Zinc Glycinate

            Therapeutic Area: Infections and Infectious Diseases Product Name: Goimmune Strong

            Highest Development Status: Approved Product Type: Small molecule

            Partner/Sponsor/Collaborator: University of Latvia

            Deal Size: Not Applicable Upfront Cash: Not Applicable

            Deal Type: Not Applicable February 02, 2021

            ASK
            US
            PHARMACOMPASS
            Upload
            your Pipeline Activity

            Details:

            GoRelax (lactium), specially patented cow’s milk protein split, has shown that this rotein improves sleep and is a natural anti-anxiety agent that helps reduce signs of stress.

            Lead Product(s): Lactium,Ginseng Extract,Crocus Sativus

            Therapeutic Area: Neurology Product Name: GoRelax Day

            Highest Development Status: Approved Product Type: Small molecule

            Partner/Sponsor/Collaborator: University of Lorraine

            Deal Size: Not Applicable Upfront Cash: Not Applicable

            Deal Type: Not Applicable March 26, 2020

            ASK
            US
            PHARMACOMPASS
            Upload
            your Pipeline Activity

            Details:

            GoImmune STRONG (tabebuia avellandae extract), a unique remedy for the season of the common cold, which includes green propolis, tabebuia bark and olive leaf extracts, as well as zinc and selenium.

            Lead Product(s): Tabebuia Avellandae Extract,Olea Europea Extract,Zinc Glycinate

            Therapeutic Area: Infections and Infectious Diseases Product Name: GoImmune STRONG

            Highest Development Status: Approved Product Type: Small molecule

            Partner/Sponsor/Collaborator: Not Applicable

            Deal Size: Not Applicable Upfront Cash: Not Applicable

            Deal Type: Not Applicable February 28, 2020

            ASK
            US
            PHARMACOMPASS
            Upload
            your Pipeline Activity
            Post Enquiry
            POST ENQUIRY